CheckMyRecalls

SUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USP

Published
21 Jan 2026
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 21 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.